(ORMP) Oramed Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Oramed Pharmaceuticals | (ORMP) share price targets
Complete technical analysis of Oramed Pharmaceuticals (ORMP) by charts plus indicators, forecast predictions and share price targets for Oramed Pharmaceuticals (ORMP)
Oramed Pharmaceuticals trades in USA in Health Care sector.
10 day averaged volume of Oramed Pharmaceuticals is 109400
| Date | Daily Closing Price | Open | High | Low | Volume |
| 14 Mon Apr 2025 | 2.27 | 2.20 | 2.30 | 2.20 | 1.079 times |
| 11 Fri Apr 2025 | 2.11 | 2.10 | 2.15 | 2.09 | 0.862 times |
| 10 Thu Apr 2025 | 2.13 | 2.11 | 2.13 | 2.01 | 0.49 times |
| 09 Wed Apr 2025 | 2.12 | 2.02 | 2.21 | 1.82 | 2.363 times |
| 08 Tue Apr 2025 | 2.03 | 2.16 | 2.26 | 2.03 | 0.933 times |
| 07 Mon Apr 2025 | 2.10 | 2.05 | 2.12 | 2.04 | 0.575 times |
| 04 Fri Apr 2025 | 2.10 | 2.15 | 2.19 | 2.06 | 0.932 times |
| 03 Thu Apr 2025 | 2.16 | 2.12 | 2.37 | 2.12 | 1.414 times |
| 02 Wed Apr 2025 | 2.20 | 2.11 | 2.20 | 2.11 | 0.585 times |
| 01 Tue Apr 2025 | 2.13 | 2.16 | 2.16 | 2.06 | 0.834 times |
My analysis of stock is bullish for shortterm, and stock might move up till 2.4 or till 2.5. Use a stoploss of 2.23 and if this stock hits its stoploss, then it can fall down till 2.11
Share price targets for Oramed Pharmaceuticals (ORMP)
| Target Type | Value |
| Downside Target | 1.82 |
| Downside Target | 1.96 |
| Downside Target | 2.06 |
| Downside Target | 2.18 |
| Downside Target | 2.26 |
| Upside Target | 2.36 |
| Upside Target | 2.37 |
| Upside Target | 2.46 |
| Upside Target | 2.50 |
| Upside Target | 2.56 |
| Upside Target | 2.68 |
| Upside Target | 3.09 |
Intraday share price targets for Oramed Pharmaceuticals (ORMP)
| Target Type | Value |
| Downside Intraday Target | 2.21 |
| Downside Intraday Target | 2.16 |
| Upside Intraday Target | 2.31 |
| Upside Intraday Target | 2.36 |
| Downside Intraday Target | 2.26 |
Weekly technical analysis of Oramed Pharmaceuticals (ORMP)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 14 Mon Apr 2025 | 2.27 | 2.20 | 2.30 | 2.20 | 0.207 times |
| 11 Fri Apr 2025 | 2.11 | 2.05 | 2.26 | 1.82 | 1.093 times |
| 04 Fri Apr 2025 | 2.10 | 2.21 | 2.37 | 2.06 | 5.524 times |
| 28 Fri Mar 2025 | 2.21 | 2.33 | 2.36 | 2.18 | 0.594 times |
| 21 Fri Mar 2025 | 2.33 | 2.40 | 2.46 | 2.31 | 0.221 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Oramed Pharmaceuticals (ORMP)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 14 Mon Apr 2025 | 2.27 | 2.16 | 2.37 | 1.82 | 0.452 times |
| 31 Mon Mar 2025 | 2.14 | 2.08 | 2.68 | 1.96 | 0.235 times |
| 28 Fri Feb 2025 | 2.09 | 2.18 | 3.09 | 2.06 | 4.172 times |
| 31 Fri Jan 2025 | 2.24 | 2.45 | 2.50 | 2.18 | 0.8 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Oramed Pharmaceuticals (ORMP)
Price action analysis of Oramed Pharmaceuticals ( (ORMP) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Oramed Pharmaceuticals ( (ORMP) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Oramed Pharmaceuticals ( (ORMP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Oramed Pharmaceuticals ( (ORMP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Oramed Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Oramed Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Oramed Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Oramed Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Oramed Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.14 and Oramed Pharmaceuticals (ORMP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Oramed Pharmaceuticals (ORMP) stock. Volume based technical analysis of Oramed Pharmaceuticals (ORMP) stock is negative.
Oramed Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Oramed Pharmaceuticals ( (ORMP) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Oramed Pharmaceuticals ( (ORMP) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Oramed Pharmaceuticals ( (ORMP) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Oramed Pharmaceuticals ( (ORMP) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Oramed Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is gaining momentum.
MACD generated a BUY signal for Oramed Pharmaceuticals in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Oramed Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Oramed Pharmaceuticals in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Oramed Pharmaceuticals is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.14 and Oramed Pharmaceuticals (ORMP) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is rising upwards.
People seem to be coming out and selling the Oramed Pharmaceuticals (ORMP) stock. Volume based technical analysis of Oramed Pharmaceuticals (ORMP) stock is negative.
Oramed Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.